In this week's Cancer Disparities podcast, Dr Otis Brawley speaks with Dr Michael Carducci about the benefit of clinical trials and his work treating patients with prostate cancer.
Research

Cancer Matters with Dr. Bill Nelson – Cancer Genomics
Posted by Clinton | podcastOur next Cancer Matters podcast is now online. Today, Dr Bill Nelson talks with Dr Srinivasan Yegnasubramanian about his research into cancer genomics. In this preview, Dr Yegnasubramanian explains how genes work. To listen, click here: http://bit.ly/2nYZcRy
Oct 3, 2019 No comments

Cancer Matters with Dr. Bill Nelson – Pathology
Posted by Clinton | podcastIn this podcast from Johns Hopkins Kimmel Cancer Center Director Dr Bill Nelson, he talks to Dr Angelo De Marzo about the role of a pathologist in diagnosing a disease as well as his findings affirming the inconsistent use of research antibodies. In this preview, Dr De Marzo explains how antibodies are used in a lab and […]
May 30, 2019 No comments

Cancer Interception: Kimmel Experts Part of New Stand Up To Cancer Project
Posted by Michelle Potter | Research, treatmentStand Up To Cancer launched four new teams aimed at detecting and treating cancer in its earliest stages. Lung cancer expert Julie Brahmer, M.D., is the lead investigator for Johns Hopkins for lung cancer studies based at the Kimmel Cancer Center Thoracic Center of Excellence she directs. Victor Velculescu, M.D., Ph.D., an expert in the […]
Dec 8, 2017 No comments
Creativity Competition Creates New Ideas to Cure Cancer
Posted by admin | ResearchLast Friday, the historic Hurd Hall at Johns Hopkins was filled to capacity with students, faculty and staff waiting to hear five scientists – all in the early part of their careers – describe their novel ideas on how to cure metastatic cancer. It was part of a competition on creative thinking named for John […]
Jan 20, 2012 30 comments
What Matters to You?
Posted by admin | Issues & Perspectives, ResearchIt was the culmination of years of effort by many scientists and physicians and the bravery of patients to try something new that has brought some steady hope in an experimental therapy called epigenetics.
Oct 1, 2010 No comments